Welcome, . This video requires ASBrS membership.
Learn more about Society membership.
Great Debates in Breast Cancer
May 4, 2019
Moderator
Anees Chagpar, MD
Presenters
- Have Margin Consensus Guidelines Significantly Reduced Re-Excision Rates? Yes
Swati Kulkarni, MD - Have Margin Consensus Guidelines Significantly Reduced Re-Excision Rates? No
Rogsbert Phillips, MD - Following Neoadjuvant Chemotherapy, Should the Extent of Surgery and Radiotherapy Be Based on the Presenting Stage? Yes
Terry Mamounas, MD - Following Neoadjuvant Chemotherapy, Should the Extent of Surgery and Radiotherapy Be Based on the Presenting Stage? No
Hiram Cody, III, MD - Neoadjuvant Endocrine Therapy is Better Than Neoadjuvant Chemotherapy for Hormone Receptor-Positive Breast Cancer? Agree
J. Michael Dixon, OBE, MD - Neoadjuvant Endocrine Therapy is Better Than Neoadjuvant Chemotherapy for Hormone Receptor-Positive Breast Cancer? Disagree
Kelly Hunt, MD
